−5.9774USD
−14.65 MUSD
55.20 M
About Kintara Therapeutics, Inc.
Sector
Industry
CEO
Robert E. Hoffman
Website
Headquarters
San Diego
Employees (FY)
17
Founded
2009
ISIN
US49720K2006
FIGI
BBG001J7N7K8
Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KTRA is 0.1066 USD — it has increased by 2.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Kintara Therapeutics, Inc. stocks are traded under the ticker KTRA.
Kintara Therapeutics, Inc. is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
KTRA stock is 5.54% volatile and has beta coefficient of −3.89. Check out the list of the most volatile stocks — is Kintara Therapeutics, Inc. there?
KTRA earnings for the last quarter are −1.83 USD whereas the estimation was −0.58 USD which accounts for −215.52% surprise. Estimated earnings for the next quarter are −0.14 USD. See more details about Kintara Therapeutics, Inc. earnings.
Yes, you can track Kintara Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
KTRA stock has fallen by 10.27% compared to the previous week, the month change is a 21.14% rise, over the last year Kintara Therapeutics, Inc. has showed a 96.73% decrease.
KTRA net income for the last quarter is −1.02 M USD, while the quarter before that showed −2.96 M USD of net income which accounts for 65.46% change. Track more Kintara Therapeutics, Inc. financial stats to get the full picture.
Today Kintara Therapeutics, Inc. has the market capitalization of 5.74 M, it has increased by 33.96% over the last week.
No, KTRA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, KTRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kintara Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 17.00 employees. See our rating of the largest employees — is Kintara Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kintara Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kintara Therapeutics, Inc. stock shows the sell signal. See more of Kintara Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.